Scenario.press - libera espressione Scenario.press - libera espressione
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Marketplace
  • Financement
  • Offres
  • Emplois
  • Courses
  • Film
  • Développeurs
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • akshayg Ajouter une nouvelle offre d'emploi Autre
    2025-05-19 13:59:27 -
    Ulcerative Colitis Therapeutics Market Analyzing Demand In-Depth: Size, Growth Outlook Elevated by Fact MR
    The global ulcerative colitis therapeutics market is valued at USD 7.2 billion in 2025. As per Fact.MR analysis, the industry will grow at a CAGR of 5.1% and will reach USD 11.9 billion by 2035. Ulcerative colitis, a type of chronic inflammatory bowel disease, causes acute inflammation and ulceration in the large bowel and rectum. In 2024, the therapeutics industry for ulcerative...
    0 Commentaires 0 Parts 1KB Vue
    Connectez-vous pour aimer, partager et commenter!
  • johnbailey Ajouter une nouvelle offre d'emploi Health
    2025-10-09 08:33:47 -
    Common Misdiagnoses Between Ulcerative Proctitis and Other GI Issues
    Gastrointestinal (GI) conditions are notoriously tricky to diagnose, given the overlapping symptoms among different disorders. Patients may experience rectal bleeding, abdominal cramping, urgency, or diarrhea, and yet the underlying cause could range from hemorrhoids to irritable bowel syndrome (IBS) to inflammatory bowel disease (IBD). One area where this overlap often leads to diagnostic...
    0 Commentaires 0 Parts 69 Vue
    Connectez-vous pour aimer, partager et commenter!
© 2025 Scenario.press - libera espressione French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidentialité Business Model Dons Contactez nous Annuaire